Biblio Discovery — Demo Discovery Service

17 hasil untuk "Simmons, Adam"

Menampilkan 1–17 · 0,19 detik · RSS

  1. Buku Teks lengkap

    Dotawo: A Journal of Nubian Studies 6: Miscellanea Nubiana

    Simmons, Adam

    2026 · Inggris · Zenodo

    Dotawo: A Journal of Nubian Studies offers a platform in which the old meets the new, in which archaeological, papyrological, and philological research into Meroitic, Old Nubian, Coptic, Greek, and Arabic sources confront current investigations in modern anthropology and ethnography, Nilo-Saharan…

  2. Artikel Jurnal Teks lengkap

    Layperson/Plain Language Summaries: Can Sponsors, CROs, and Sites Deliver in 2020?

    Wilcox, Charles S.; Franceschi, Leslie; Simmons, Adam

    Innov Clin Neurosci · 2020 · Inggris · PubMed Central

    The much-anticipated 2014 European Union (EU) Clinical Trial Regulation requiring Layperson/ Plain Language Summaries (PLS) is slated for implementation in 2020. At the 10th Annual CNS Summit Conference (Fall 2019), a panel discussion was convened with the objective of evaluating the likelihood of…

  3. Artikel Jurnal Teks lengkap

    S226. A STUDY COMPARING WEIGHT GAIN FROM ALKS 3831 TO OLANZAPINE IN EARLY-ILLNESS YOUNG ADULTS WITH SCHIZOPHRENIFORM, SCHIZOPHRENIA, OR BIPOLAR I DISORDER

    Simmons, Adam; McDonnell, David; Jiang, Ying dkk.

    Schizophr Bull · 2018 · Inggris · PubMed Central

    BACKGROUND: Optimal pharmacological efficacy is crucial in first-episode and early-episode schizophrenia and bipolar I disorder. Olanzapine (OLZ) is a highly efficacious antipsychotic indicated for the treatment of schizophrenia and bipolar I disorder. However, the clinical utility of OLZ may be…

  4. Artikel Jurnal Teks lengkap

    T24. A PHASE 3, MULTICENTER STUDY TO ASSESS THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF ALKS 3831 IN SUBJECTS WITH SCHIZOPHRENIA

    Yagoda, Sergey; Graham, Christine; Simmons, Adam dkk.

    Schizophr Bull · 2019 · Inggris · PubMed Central

    BACKGROUND: ALKS 3831, currently under development for the treatment of schizophrenia, is composed of a flexible dose of olanzapine and a fixed dose of 10 mg of samidorphan. Samidorphan is intended to mitigate weight gain associated with olanzapine treatment alone. Here, we report the safety…

  5. Artikel Jurnal Teks lengkap

    Second-order cues to figure motion enable object detection during prey capture by praying mantises

    Nityananda, Vivek; O’Keeffe, James; Umeton, Diana dkk.

    Proc Natl Acad Sci U S A · 2019 · Inggris · PubMed Central

    Detecting motion is essential for animals to perform a wide variety of functions. In order to do so, animals could exploit motion cues, including both first-order cues—such as luminance correlation over time—and second-order cues, by correlating higher-order visual statistics. Since first-order…

  6. Artikel Jurnal Teks lengkap

    Use of a blood‐based amyloid test for screening in INVOKE‐2: a phase 2 randomized, double‐blind, placebo‐controlled study evaluating AL002 in early Alzheimer’s disease

    Burgess, Brady; Nguyen, Tuan; Simmons, Adam dkk.

    Alzheimers Dement · 2025 · Inggris · PubMed Central

    BACKGROUND: The PrecivityAD® blood‐test (C2N Diagnostics) predicts cerebral amyloidosis due to Alzheimer’s Disease (AD). PrecivityAD® incorporates plasma Aβ42/40, age and apoE proteotype into an algorithm that generates an amyloid probability score (APS) corresponding to the likelihood of a…

  7. Artikel Jurnal Teks lengkap

    F232. A PHASE 3 STUDY TO DETERMINE THE ANTIPSYCHOTIC EFFICACY AND SAFETY OF ALKS 3831 IN ADULT PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA

    McDonnell, David; Potkin, Steven G; Simmons, Adam dkk.

    Schizophr Bull · 2018 · Inggris · PubMed Central

    BACKGROUND: ALKS 3831, currently under development for the treatment of schizophrenia, is composed of a flexible dose of olanzapine (OLZ) and a fixed dose of 10 mg of samidorphan. In a Phase 2 study, ALKS 3831 mitigated OLZ-associated weight gain and exhibited antipsychotic efficacy similar to OLZ…

  8. Artikel Jurnal Teks lengkap

    Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis

    Correll, Christoph U; Højlund, Mikkel; Graham, Christine dkk.

    Int J Neuropsychopharmacol · 2023 · Inggris · PubMed Central

    BACKGROUND: Patients with first-episode psychosis or early-phase schizophrenia are susceptible to olanzapine-associated weight gain and cardiometabolic dysregulation. This meta-analysis characterized weight and metabolic effects observed during olanzapine treatment in randomized clinical trials in…

  9. Artikel Jurnal Teks lengkap

    Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia

    Achtyes, Eric; Simmons, Adam; Skabeev, Anna dkk.

    BMC Psychiatry · 2018 · Inggris · PubMed Central

    BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess…

  10. Artikel Jurnal Teks lengkap

    Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients

    Simmons, Adam; O’Sullivan, Amy K.; Carpenter-Conlin, Julia dkk.

    Front Psychiatry · 2024 · Inggris · PubMed Central

    INTRODUCTION: Qualitative research methods can be used to obtain a deeper understanding of patient experience by collecting information in the patients’ own words about their encounters, perspectives, and feelings. In this study, patients with schizophrenia were interviewed to capture their voice…

  11. Artikel Jurnal Teks lengkap

    Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

    Citrome, Leslie; O’Malley, Stephanie S.; McDonnell, David dkk.

    Innov Clin Neurosci · 2019 · Inggris · PubMed Central

    Background: Alcohol use disorder (AUD) is a common comorbidity in patients with schizophrenia. Although pharmacological options for the management of each disease exist separately, there is no agent approved for both. Moreover, studies conducted in this patient population, who face practical and…

  12. Artikel Jurnal Teks lengkap

    An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder

    Citrome, Leslie; Graham, Christine; Simmons, Adam dkk.

    Neuropsychiatr Dis Treat · 2021 · Inggris · PubMed Central

    Olanzapine effectively treats schizophrenia and bipolar I disorder (BD-I); however, its use is limited by the risk of significant weight gain and metabolic effects. OLZ/SAM, a combination of olanzapine and samidorphan, was recently approved in the United States for the treatment of adults with…

  13. Artikel Jurnal Teks lengkap

    Vaginal Microbicide Gel for Delivery of IQP-0528, a Pyrimidinedione Analog with a Dual Mechanism of Action against HIV-1

    Mahalingam, Alamelu; Simmons, Adam P.; Ugaonkar, Shweta R. dkk.

    Antimicrob Agents Chemother · 2011 · Inggris · PubMed Central

    Pyrimidinediones, a novel class of compounds, have previously been shown to possess antiviral activity at nanomolar concentrations. One member of this class of compounds, IQP-0528, was selected as the lead molecule for formulation development owing to its stability at physiologically relevant…

  14. Artikel Jurnal Teks lengkap

    Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis

    Genge, Angela; van den Berg, Leonard H.; Frick, Glen dkk.

    JAMA Neurol · 2023 · Inggris · PubMed Central

    IMPORTANCE: Additional therapies for amyotrophic lateral sclerosis (ALS) are urgently needed. Immune-mediated complement activation may be involved in ALS pathogenesis as evidenced by the upregulation of terminal components; thus, complement inhibition could potentially slow progression. OBJECTIVE…

  15. Artikel Jurnal Teks lengkap

    Maternal Cytomegalovirus-Specific Immune Responses and Symptomatic Postnatal Cytomegalovirus Transmission in Very Low-Birth-Weight Preterm Infants

    Ehlinger, Elizabeth P.; Webster, Emily M.; Kang, Helen H. dkk.

    J Infect Dis · 2011 · Inggris · PubMed Central

    Introduction. Transmission of cytomegalovirus (CMV) via breast milk can lead to severe acute illness in very low-birth-weight (VLBW) preterm infants. Although the majority of CMV-seropositive women shed CMV in milk, symptomatic postnatal infection of VLBW infants occurs infrequently, suggesting…

  16. Artikel Jurnal Teks lengkap

    Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease

    Long, Hua; Simmons, Adam; Mayorga, Arthur dkk.

    Alzheimers Res Ther · 2024 · Inggris · PubMed Central

    BACKGROUND: Variants of the gene triggering receptor expressed on myeloid cells-2 (TREM2) increase the risk of Alzheimer’s disease (AD) and other neurodegenerative disorders. Signaling by TREM2, an innate immune receptor expressed by microglia, is thought to enhance phagocytosis of amyloid beta…

  17. Artikel Jurnal Teks lengkap

    Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor

    Isaacson, Stuart H.; Peckham, Elizabeth; Tse, Winona dkk.

    Tremor Other Hyperkinet Mov (N Y) · 2020 · Inggris · PubMed Central

    HIGHLIGHTS: This prospective study is one of the largest clinical trials in essential tremor to date. Study findings suggest that individualized non-invasive neuromodulation therapy used repeatedly at home over three months results in safe and effective hand tremor reduction and improves quality of…